UCB buys epilepsy firm Engage Tx in $270m deal

UCB buys epilepsy firm Engage Tx in $270m deal

Submitted by admin on June 8, 2020 - 10:30am
Source: 
PM Live
News Tags: 
UCB Pharma
epilepsy
M&A
Engage Therapeutics
drug-device combos
Staccato Alprazolam
Headline: 
UCB buys epilepsy firm Engage Tx in $270m deal
snippet: 

Belgium drugmaker UCB has bolstered its epilepsy franchise with the acquisition of US biotech Engage Therapeutics and its experimental drug-device combination therapy Staccato Alprazolam.

Do Not Allow Advertisers to Use My Personal information